Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus APWC Q3 1997 Earnings Missed Estimates Amid Operational Challenges EXP Q1 2026 Earnings EPS Surges Past Estimates Strong Operational Performance JSM Q1 2026 Earnings Navient Beats EPS Estimates by 2225 Note Price Unchanged AMPY Q1 2026 Earnings Significant earnings miss as reported loss of 093 per share versus consensus estimate Twilio Q1 2026 Earnings EPS Surges Past Expectations Stock Declines Despite Beat